Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of ($0.12), $0.06 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $3.22 million versus the consensus estimate of $3 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.